The gap between label and effect

You buy a supplement, read the label, take the stated dose — and assume the number on the bottle is the number your body receives. It rarely is.

Formulation quality alone can account for up to 75% loss in bioavailability for a nutrient like CoQ10, where the physical dispersion of particles in the capsule determines how much the gut can actually absorb. Same molecule. Same milligrams. Profoundly different outcome depending on how it was made. That gap — between label dose and absorbed dose — is not a fringe concern for pharmaceutical scientists. For everyday supplement users, it is quietly operating every time they open a bottle.

Professor Paul Lee's Chemistry pillar, set out in Regeneration by Design, frames the body's internal environment as the decisive variable: what matters is not what you consume but what your physiology can use. Nutrient delivery is a transaction that requires both sides to cooperate — the formulation must present the molecule in a form the gut can process, and the gut must have the conditions to receive it. When either side fails, the label number is fiction.

This matters most for four nutrients that sit at the heart of recovery and vitality: omega-3 fatty acids, vitamin D, magnesium, and collagen. Each has a delivery-form problem. Each has a solution — if you know where to look.

How liposomal, nano-emulsified and food-matrix delivery actually work

Three distinct engineering approaches have emerged to close the delivery gap — and each targets a different point of failure.

Liposomal delivery wraps the active nutrient inside a tiny lipid bilayer vesicle — essentially a miniature version of the membrane surrounding every human cell. The gut wall recognises this structure, which enables lymphatic uptake and allows the contents to bypass the harsh gastric environment that degrades many nutrients before they reach the small intestine. A scoping review of ten clinical trials found that nine of ten demonstrated liposomal formulations producing 1.2–5.4 times higher peak plasma levels (Cmax) and 1.3–7.2 times higher overall exposure (AUC) compared to standard non-liposomal equivalents. Most trials measured circulating levels rather than confirmed cellular uptake, so the plasma advantage may not yet translate into verified tissue benefit in every context — but the absorption signal is consistent.

Nano-emulsified and self-emulsifying systems (variously labelled SMEDS, nano-emulsions, or liquid crystalline nanoparticles) attack a different problem: the fat-dissolving step. Many fat-soluble nutrients depend on the body generating sufficient bile and dietary-fat context to form the emulsified droplets that lipase enzymes can act on. Reducing particle size to nanoscale dramatically increases the surface area available for lipase action — and self-emulsifying formulations can partly generate their own emulsion, reducing dependence on co-ingested dietary fat.

Food-matrix delivery is the oldest mechanism and in some respects the least mechanistically understood. Co-ingesting certain nutrients alongside fermented milk, yogurt, or specific whole foods enhances absorption through routes that extend beyond simply supplying fat — likely involving food-derived peptides, microbiota-related factors, and bioactive compounds that fermentation pre-generates before the food is even consumed.

None of these is interchangeable with the others, and none is universally superior. The right approach depends on which absorption bottleneck a given nutrient actually faces — which is where the nutrient-specific evidence becomes the essential guide.

Omega-3 EPA/DHA: where the evidence is strongest

Of all the nutrients where delivery form has been tested head-to-head with specific numbers, omega-3 fatty acids provide the clearest data — and the most immediately actionable finding.

Standard ethyl ester capsules dominate the lower-price end of the omega-3 market. Their absorption problem is mechanical: ethyl esters require the body's own lipase enzymes and bile salts to break the ester bond and release EPA and DHA. In the fasted state, both bile output and lipase activity are minimal. The result is that much of the stated dose may pass through largely unabsorbed — which is why the food effect on this format is so dramatic.

A randomised crossover trial quantified this precisely. A self-emulsifying formulation — which generates its own emulsion rather than depending on bile and co-ingested fat — produced an 8.2-fold higher combined EPA and DHA plasma exposure in fasted adults compared to a standard ethyl ester capsule, with EPA individually 18.2 times higher and DHA 4.5 times higher.

Phospholipid and free-fatty-acid forms, the dominant structure in krill oil, take a different route. In a comparative study they produced approximately five times higher fasted EPA and DHA exposure than ethyl esters. Crucially, the food effect for phospholipid forms was only 1.7-fold (fed versus fasted), compared to 25-fold for ethyl esters — meaning this format is far less sensitive to whether you take it with a meal.

A third format, liquid crystalline nanoparticles, delivered 110% higher EPA and 134% higher DHA bioavailability over 72 hours compared to the standard ethyl ester prescription product Omacor® in a crossover study of 24 healthy adults.

Taking a standard ethyl ester omega-3 without fat in the stomach may deliver a fraction of the label dose. Format and meal timing together determine effective intake — and since EPA and DHA tissue incorporation directly influences inflammatory regulation, that gap is not a theoretical one.

Magnesium, Vitamin D, and Collagen — form, timing, and context

The omega-3 story is unusually tidy because the absorption bottleneck is mechanical and well-defined. The remaining three nutrients each add a different dimension to what 'delivery form' actually means — and the evidence grows progressively less clean, which is itself useful information.

Magnesium is a case where form selection should follow intended outcome, not merely a general absorption ranking. Organic forms — citrate, malate, glycinate, acetyl taurate — absorb better than inorganic forms as a class. The more practically useful distinction, however, is tissue destination. Magnesium acetyl taurate is the only compound documented to reliably elevate magnesium levels in the brain across doses tested; magnesium citrate increases both brain and muscle levels. Splitting a high daily dose into smaller increments did not reliably improve tissue accumulation. Choosing the form with the highest general absorption efficiency is not the same as choosing the form best suited to the tissue you are trying to supply.

Vitamin D introduces a further layer of complexity: bile salt availability, intestinal health, co-ingested fat type, and individual variation all modulate cholecalciferol absorption, making head-to-head format comparisons harder to generalise cleanly than with omega-3. Within that complexity, one finding stands out as counterintuitive. Unlike vitamins E, K, and A — all of which showed differential responses to long- versus medium-chain triglycerides — vitamin D plasma response was not significantly affected by oil type, suggesting its micellarisation dynamics follow a different route. More striking still, co-ingestion with non-fat fermented milk significantly raised cholecalciferol plasma AUC in healthy males compared with water alone — without any dietary fat involved — pointing to food-matrix mechanisms that extend well beyond fat delivery.

Collagen peptides offer a parallel discovery. Source (fish, porcine, bovine) and molecular weight (2–5 kDa) had minimal impact on plasma absorption equivalency; hydroxyproline-containing di- and tripeptides were detectable in blood across all types. What did matter was food context: yogurt co-ingestion — fermented or not — significantly enhanced Cmax and AUC compared with water. Fermentation added a further step, pre-generating bioactive dipeptides Ala-Hyp, Leu-Hyp, and Phe-Hyp within the yogurt matrix before ingestion.

The common thread across all three is that context — tissue target, GI environment, and what surrounds the supplement at the moment of ingestion — shapes outcome more reliably than any single formulation choice.

What 'test first' looks like in practice

Knowing that label dose rarely equals absorbed dose raises an obvious next question: how does anyone confirm whether their current supplements are actually working?

Three markers make that question answerable. Serum 25-OH vitamin D is the standard readout for vitamin D status — a baseline before starting or switching a format, then a repeat test after 8–12 weeks to confirm whether circulating levels have moved. The omega-3 index — erythrocyte EPA+DHA as a percentage of total red blood cell fatty acids — reflects tissue incorporation over weeks rather than a single-dose response, making it a far more meaningful indicator of effective omega-3 delivery than any short-term plasma snapshot. RBC magnesium is the more informative magnesium marker; serum magnesium is tightly regulated and can remain stable even when tissue stores are genuinely depleted, so serum alone tends to understate the deficit.

One honest caveat belongs here: direct trial evidence comparing 'test-and-adjust' protocols to untested supplementation is currently sparse. The case for testing rests on the well-documented label-to-absorption gap and the considerable individual variation in bile output, intestinal health, and metabolic processing — not on trials of the protocol itself. The logic is sound; the formal proof is not yet there.

In Professor Paul Lee's framework, this is where Chemistry and Time converge. A marker measured once is a data point; measured before a format change and again at 8–12 weeks, it becomes a feedback loop — the monitoring rhythm that transforms supplementation from a hopeful assumption into a monitored system, which is precisely what Regeneration by Design means by systemic thinking.

From isolated supplements to a designed system

Delivery form, baseline testing, and meal timing do not exist in isolation — they are Chemistry pillar decisions that feed directly into what the other three pillars can achieve. Better omega-3 tissue incorporation supports joint loading and movement quality (Physics); an adequate magnesium supply affects sleep architecture and nervous system recovery (Biology); both interact across the timescales that govern when repair actually occurs (Time). Optimising one element without reference to the others misses precisely the interdependence that Professor Paul Lee's Regeneration by Design framework was built to address.

The practical architecture is straightforward. Audit current supplement formats against the delivery-form evidence: does the omega-3 label specify ethyl ester, phospholipid, or an emulsified system? Is the magnesium compound matched to the tissue you are trying to reach? Run the relevant baseline markers before making any change — serum 25-OH vitamin D, omega-3 index, RBC magnesium — then repeat at eight to twelve weeks. Without that measurement loop, switching formats remains an assumption, just a better-informed one.

Practical Regeneration offers the organising framework for folding these decisions into an ongoing personal health design rather than a one-off supplement audit. The Chemistry pillar is not a shopping list; it is a system specification. The right question is not 'what dose?' but 'what form, measured how, at what interval?' — and that question, asked consistently, is what separates designed nutrition from guesswork.

1. [1] Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism. (2020). https://doi.org/10.3390/antiox9050386 https://doi.org/10.3390/antiox9050386
2. [2] Advancements in Spray-Drying for the Microencapsulation of Fat-Soluble Vitamins: Stability, Bioavailability, and Applications. (2025). https://doi.org/10.1155/jfbc/9974476 https://doi.org/10.1155/jfbc/9974476
3. [3] Enhancing Bioavailability and Stability of Fat-Soluble Vitamins Through Interactions With Food Macromolecules: Modern Technological Approaches. (2025). https://doi.org/10.1111/1541-4337.70362 https://doi.org/10.1111/1541-4337.70362
4. [4] Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of EPA and DHA in a Fasted State. (2018). https://doi.org/10.1016/j.clinthera.2018.10.014 https://doi.org/10.1016/j.clinthera.2018.10.014
5. [5] A Single-dose, Comparative Bioavailability Study of OM3 Phospholipid/Free Fatty Acid Versus Ethyl Ester in Fasting and Fed States. (2019). https://doi.org/10.1016/j.clinthera.2019.01.017 https://doi.org/10.1016/j.clinthera.2019.01.017
6. [6] Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. (2025). https://doi.org/10.1111/bcpt.70067 https://doi.org/10.1111/bcpt.70067
7. [7] Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates. (2019). https://doi.org/10.1097/MCO.0000000000000537 https://doi.org/10.1097/MCO.0000000000000537
8. [8] Factors influencing the absorption of vitamin D in GIT: an overview. (2017). https://doi.org/10.1007/s13197-017-2840-0 https://doi.org/10.1007/s13197-017-2840-0
9. [9] Bioavailability. https://en.wikipedia.org/?curid=769021 https://en.wikipedia.org/?curid=769021
10. [10] A Randomized, Open-Label, Single-Dose, Crossover Study of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation vs Omacor® Soft Capsule. (2023). https://doi.org/10.3390/ijms242417201 https://doi.org/10.3390/ijms242417201
11. [11] Dose-Dependent Absorption Profile of Different Magnesium Compounds. (2019). https://doi.org/10.1007/s12011-019-01663-0 https://doi.org/10.1007/s12011-019-01663-0
12. [12] Bioavailability of Liposomal Vitamin C in Powder Form: A Randomized, Double-Blind, Cross-Over Trial. (2024). https://doi.org/10.3390/app14177718 https://doi.org/10.3390/app14177718